Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)trial; part of the JACTAX stent program. [30] The JACTAX stent con ...
Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.
The team from Doylestown Health's Vascular Surgery is the first in the greater Philadelphia region to use the Abbott ...
Vascular surgeons at Doylestown Hospital have pioneered a dissolvable stent that holds clogged arteries open long enough to ...
The use of drug-eluting stents (DES) has become widespread as a result of their superior revascularization rates compared with those of bare-metal stents (BMS). 1 DES are increasingly being used ...
The following is a summary of “Effectiveness and Safety of Ticagrelor Monotherapy After Short-Duration Dual Antiplatelet ...
Polymer-free stents show comparable PCI results but with increased early thrombosis risk, impacting clinical choices.
India’s coronary stent market is projected to reach USD 1,213.5 million by 2033, growing at a CAGR of 3.7%. The increasing ...
The company has projected an over 20% revenue growth for the next 2-3 years, the management has said. Poly Medicure also ...
Poly Medicure Ltd (BOM:531768) reports robust financial performance with a 24.9% revenue increase, while navigating hurdles in the dialysis sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results